Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
12/20/2012 | US20120322867 Methods of Treating an Overweight or Obese Subject |
12/20/2012 | US20120322865 Sustained polypeptide expression from synthetic, modified rnas and uses thereof |
12/20/2012 | US20120322851 Oral delivery of therapeutically effective lna oligonucleotides |
12/20/2012 | US20120322844 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
12/20/2012 | US20120322837 Amide compound and medicinal use thereof |
12/20/2012 | US20120322822 Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome |
12/20/2012 | US20120322821 Ghrelin receptor agonist for treatment of cachexia |
12/20/2012 | US20120322819 Compound containing a novel 4-alkoxypyrimidine structure and medicine containing same |
12/20/2012 | US20120322810 New salts |
12/20/2012 | US20120322809 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
12/20/2012 | US20120322808 Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS |
12/20/2012 | US20120322806 Quinoxalinedione derivatives |
12/20/2012 | US20120322804 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
12/20/2012 | US20120322798 Modulators of ATP-Binding Cassette Transporters |
12/20/2012 | US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists |
12/20/2012 | US20120322787 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
12/20/2012 | US20120322778 Pharmaceutical compositions |
12/20/2012 | US20120322761 Heterocyclic cetp inhibitors |
12/20/2012 | US20120322756 Metabolic imprinting effects of structured lipids |
12/20/2012 | US20120322754 Novel use for scopolin and derivatives thereof |
12/20/2012 | US20120322728 Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases |
12/20/2012 | US20120322726 Therapeutic agent for eating disorders |
12/20/2012 | US20120322725 Glucagon antagonist-gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity |
12/20/2012 | US20120322724 Molecules for targeting compounds to various selected organs or tissues |
12/20/2012 | US20120322723 Use of interleukin-1 receptor antagonist for preparing medicament for preventing or treating epithelium trauma of intestinal mucosa |
12/20/2012 | US20120322717 Compounds and assays for controlling Wnt activity |
12/20/2012 | US20120321731 Pharmaceutical composition for treating diabetes |
12/20/2012 | US20120321730 Capsicum annuum extract and process thereof |
12/20/2012 | US20120321724 Method of Measuring and Monitoring In Vivo Nitrite Levels |
12/20/2012 | US20120321718 Method of Treating Lactose Intolerance Using Genetically Engineered Bacteria |
12/20/2012 | US20120321712 Pharmaceutical Composition |
12/20/2012 | US20120321710 Controlled Release and Taste Masking Oral Pharmaceutical Composition |
12/20/2012 | US20120321708 Sustained-release formulations of topiramate |
12/20/2012 | US20120321692 Methods and Dressings for Sealing Internal Injuries |
12/20/2012 | US20120321678 Intra-articularly supplementation method for treating joint diseases and injuries |
12/20/2012 | US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE |
12/20/2012 | US20120321653 Novel chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereof |
12/20/2012 | US20120321648 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes |
12/20/2012 | US20120321604 Carrier comprising non-neutralised tocopheryl phosphate |
12/20/2012 | US20120321602 Omega-3 fatty acid nutriceutical composition and optimization method |
12/20/2012 | US20120321600 Infant formula with probiotics and milk fat globule membrane components |
12/20/2012 | US20120321592 Method for Using a Bacillus Subtilis Strain to Enhance Animal Health |
12/20/2012 | US20120321556 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma |
12/20/2012 | US20120321553 Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration |
12/20/2012 | CA2839512A1 Continuous subcutaneous insulin infusion methods with a hyaluronan-degrading enzyme |
12/20/2012 | CA2839511A1 Stable formulations of a hyaluronan-degrading enzyme |
12/20/2012 | CA2839437A1 Antisense modulation of fibroblast growth factor receptor 4 expression |
12/20/2012 | CA2839296A1 Methods for increasing insulin sensitivity and treating diabetes |
12/20/2012 | CA2839244A1 A nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine |
12/20/2012 | CA2838867A1 Anti-angptl3 antibodies and uses thereof |
12/20/2012 | CA2838504A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof |
12/19/2012 | EP2535338A1 Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
12/19/2012 | EP2535330A2 Iminopyridine derivative and use thereof |
12/19/2012 | EP2535059A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf) |
12/19/2012 | EP2535053A1 Mitochondrial function improver |
12/19/2012 | EP2535051A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
12/19/2012 | EP2533798A2 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth |
12/19/2012 | EP2533796A1 Methods of treating glucose metabolism disorders |
12/19/2012 | EP2533767A1 Pharmaceutical compositions comprising a combination of metformin and sitagliptin |
12/19/2012 | CN102834413A Treatment of a metabolic disorder |
12/19/2012 | CN102834393A Apoptosis signal-regulating kinase 1 inhibitors |
12/19/2012 | CN102834103A Dietary fibre composition containing beta-glucan |
12/19/2012 | CN102827875A Recombinant adenovirus for expressing mouse nerve growth factors and preparation method thereof |
12/19/2012 | CN102827735A Health-care wine for enriching blood, relaxing bowel, reducing phlegm and depressing blood-fat |
12/19/2012 | CN102827286A Fusion protein of Exendin-4 and mutational human serum albumin, and preparation method of fusion protein |
12/19/2012 | CN102827284A Exendin or analogue containing polyethylene glycol group and preparation and application thereof |
12/19/2012 | CN102827277A Anti-human serum albumin single-chain antibody and method for connecting polypeptide drugs to carbon end thereof |
12/19/2012 | CN102827270A Pegylated exenatide ramification and use thereof |
12/19/2012 | CN102827267A Humanized pika leptin protein, gene coding same and application thereof |
12/19/2012 | CN102827221A Compound having alpha-glucosidase inhibitory activity in lotus leaves and application |
12/19/2012 | CN102827206A Pradefovir crystal |
12/19/2012 | CN102827179A Compound extracted from traditional Chinese medicine ramulus euonyrni and use thereof |
12/19/2012 | CN102827167A Octahydro-pyrrolo[3,4-b]pyrrole derivatives and use of octahydro-pyrrolo[3,4-b]pyrrole derivatives as histamine-3 receptor |
12/19/2012 | CN102827122A Glucoside derivate |
12/19/2012 | CN102827081A Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor |
12/19/2012 | CN102827001A Ilex kudingcha C.J.Tseng extract |
12/19/2012 | CN102824756A Method for screening triglyceride enzyme inhibitor from plant extract |
12/19/2012 | CN102824627A Snake bone calcium capsule powder and preparation method thereof |
12/19/2012 | CN102824599A Chinese herbal tincture for treating various skin eruptions caused by diabetes |
12/19/2012 | CN102824545A Blood sugar-reduction traditional Chinese medicine composition |
12/19/2012 | CN102824532A Traditional Chinese medicine preparation for stomach excessive heat type diabetes mellitus |
12/19/2012 | CN102824487A Preparation method of weight-reducing capsule |
12/19/2012 | CN102824480A Auxiliary blood sugar decreasing composite containing tibetan medicine edgeworthia gardneri and preparation method of composite |
12/19/2012 | CN102824475A Lipid-inhibiting weight control method for mouse |
12/19/2012 | CN102824473A Lycium ruthenicum murr total flavonoid extract and preparation method thereof |
12/19/2012 | CN102824463A Traditional Chinese medicine extract for suppressing generation of in-vitro glycosylation product and extraction method |
12/19/2012 | CN102824433A Preparation method of umbrellaleaf mixture |
12/19/2012 | CN102824423A Medicinal composition comprising albiflorin and arctiin and application |
12/19/2012 | CN102824415A Medicinal composition for treating old-age male hyperlipidemia and preparation method and application thereof |
12/19/2012 | CN102824411A Medicinal tea for treating hyperlipidaemia |
12/19/2012 | CN102824395A Five-high controlling tablets |
12/19/2012 | CN102824391A Application of kalimeris in preparation of medicament for reducing blood fat or functional foods |
12/19/2012 | CN102824387A Aralia taibaiensis saponin capsule, as well as preparation method and application thereof in preparation of antidiabetic medicines |
12/19/2012 | CN102824383A Method for extracting madagascar periwinkle herb total alkaloid |
12/19/2012 | CN102824381A Isatis root and vitamin C tablet and preparation method thereof |
12/19/2012 | CN102824376A Cordyceps sinensis powder and preparation method and application thereof |
12/19/2012 | CN102824362A Medicine composition of oral rehydration salt |
12/19/2012 | CN102824361A Composition containing glucose |
12/19/2012 | CN102824360A Powder composition containing glucose and preparation method thereof |
12/19/2012 | CN102824357A Polysaccharide sulphate pharmaceutical compound for injection |